Mechanisms of autoimmune thyroid diseases: From genetics to epigenetics

Annual Review of Pathology: Mechanisms of Disease

Volumn 9, Issue , 2014, Pages 147-156

  Tomer, Yaron ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Graves disease; Hashimoto's thyroiditis; Thyroid

Indexed keywords

AUTOIMMUNE DISEASE; GENETIC ASSOCIATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; HUMAN; REVIEW; THYROID DISEASE;

AUTOIMMUNE DISEASES; EPIGENESIS, GENETIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; THYROID DISEASES;

EID: 84897019743     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-012513-104713     Document Type: Article

References (63)

1. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, et al. 2002. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87:489-99
2. Jacobson DL, Gange SJ, Rose NR, Graham NM. 1997. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84:223-43
3. Tunbridge WMG, Evered DC, Hall R, Appleton D, Brewis M, et al. 1977. The spectrum of thyroid disease in a community: theWhickham survey. Clin. Endocrinol. 7:481-93
4. Vanderpump MPJ, Tunbridge WMG, French JM, Appleton D, Bates D, et al. 1995. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin. Endocrinol. 43:55-68
5. Kabelitz M, Liesenkotter KP, Stach B, Willgerodt H, Stablein W, et al. 2003. The prevalence of antithyroid peroxidase antibodies and autoimmune thyroiditis in children and adolescents in an iodine replete area. Eur. J. Endocrinol. 148:301-7
6. Pearce SH, Leech NJ. 2004. Toward precise forecasting of autoimmune endocrinopathy. J. Clin. Endocrinol. Metab. 89:544-47
7. Davies TF. 2000. Graves diseases: pathogenesis. In Werner and Ingbars The Thyroid: A Fundamental and Clinical Text, ed. LE Braverman, RD Utiger, pp. 518-30. Philadelphia: Lippincott Williams and Wilkins. 8th ed.
8. Weetman AP. 2000. Chronic autoimmune thyroiditis. In Werner and Ingbars The Thyroid: A Fundamental and Clinical Text, ed. LE Braverman, RD Utiger, pp. 721-32. Philadelphia: Lippincott Williams and Wilkins. 8th ed.
9. Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y. 2008. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr. Rev. 29:697-725
10. Tomer Y, Huber A. 2009. The etiology of autoimmune thyroid disease: a story of genes and environment. J. Autoimmun. 32:231-39
11. Tomer Y, Menconi F. 2009. Type 1 diabetes and autoimmune thyroiditis: the genetic connection. Thyroid 19:99-102
12. Villanueva R, Greenberg DA, Davies TF, Tomer Y. 2003. Sibling recurrence risk in autoimmune thyroid disease. Thyroid 13:761-64
13. Brix TH, Christensen K, Holm NV, Harvald B, Hegedus L. 1998. A population-based study of Graves diseases in Danish twins. Clin. Endocrinol. 48:397-400
14. Brix TH, Kyvik KO, Hegedus L. 2000. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab. 85:536-39
15. Brix TH, Kyvik KO, Christensen K, Hegedus L. 2001. Evidence for a major role of heredity in Graves disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86:930-34
16. Davies TF, Ando T, Lin RY, Tomer Y, Latif R. 2005. Thyrotropin receptor-Associated diseases: from adenomata to Graves disease. J. Clin. Investig. 115:1972-83
17. Tonacchera M, Pinchera A. 2000. Thyrotropin receptor polymorphisms and thyroid diseases. J. Clin. Endocrinol. Metab. 85:2637-39
18. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, et al. 2005. Association of the TSHR gene with Graves disease: the first disease specific locus. Eur. J. Hum. Genet. 13:1223-30
19. Tomer Y, Hasham A, Davies TF, Stefan M, Concepcion E, et al. 2013. Fine mapping of loci linked to autoimmune thyroid disease identifies novel susceptibility genes. J. Clin. Endocrinol. Metab. 98:E144-52
20. Graves PN, Tomer Y, Davies TF. 1992. Cloning and sequencing of a 1.3 kb variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem. Biophys. Res. Commun. 187:1135-43
21. Charreire J. 1989. Immune mechanisms in autoimmune thyroiditis. Adv. Immunol. 46:263-334
22. Jacobson EM, Concepcion E, Ho K, Kopp P, Toniolo JV, Tomer Y. 2011. cDNA immunization of mice with human thyroglobulin generates both humoral and T cell responses: a novel model of thyroid autoimmunity. PLoS ONE 6:e19200
23. Chen CR, Hamidi S, Braley-Mullen H, Nagayama Y, Bresee C, et al. 2010. Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies. Endocrinology 151:4583-93
24. TomerY, Ban Y, ConcepcionE, Barbesino G, Villanueva R, et al. 2003.Commonand unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet. 73:736-47
25. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y. 2003. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. USA 100:15119-24
26. Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, et al. 2006. Possible interaction between HLADRβ1 and thyroglobulin variants in Graves disease. Thyroid 16:351-55
27. Jacobson EM, Yang H, Menconi F, Wang R, Osman R, et al. 2009. Employing a recombinant HLADR3 expression system to dissect MHC II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J. Biol. Chem. 284:34231-43
28. Stefan M, Jacobson EM, Huber AK, Greenberg DA, Li CW, et al. 2011. Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon α-modulated mechanism. J. Biol. Chem. 286:31168-79
29. Jacobson EM, Huber A, Tomer Y. 2008. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J. Autoimmun. 30:58-62
30. Menconi F, Monti MC, Greenberg DA, Oashi T, Osman R, et al. 2008. Molecular amino acid signatures in theMHCclass II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc. Natl. Acad. Sci. USA 105:14034-39
31. Menconi F, Osman R, Monti MC, Greenberg DA, Concepcion ES, Tomer Y. 2010. Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc. Natl. Acad. Sci. USA 107:16899-903
32. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Osman R, et al. 2004. Arginine at position 74 of the HLA-DRβ1 chain is associated with Graves disease. Genes Immun. 5:203-8
33. Simmonds MJ, Howson JM, Heward JM, Cordell HJ, Foxall H, et al. 2005. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am. J. Hum. Genet. 76:157-63
34. Menconi F, Huber A, Osman R, Concepcion E, Jacobson EM, et al. 2010. Tg.2098 is a major human thyroglobulin T-cell epitope. J. Autoimmun. 35:45-51
35. Inaba H, MartinW, ArditoM, De Groot AS, De Groot LJ. 2010. The role of glutamic or aspartic acid in position four of the epitope bindingmotif and thyrotropin receptor-extracellular domain epitope selection in Graves disease. J. Clin. Endocrinol. Metab. 95:2909-16
36. Lee KH, Wucherpfennig KW, Wiley DC. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2:501-7
37. Jacobson EM, Tomer Y. 2007. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J. Autoimmun. 28:85-98
38. Jacobson EM, Concepcion E, Oashi T, Tomer Y. 2005. A Graves disease-Associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146:2684-91
39. Huber AK, Finkelman FD, Li CW, Concepcion E, Smith E, et al. 2012. Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J. Immunol. 189:3043-53
40. Park JH, Chang HS, Park CS, Jang AS, Park BL, et al. 2007. Association analysis of CD40 polymorphisms with asthma and the level of serum total IgE. Am. J. Respir. Crit. Care Med. 175:775-82
41. van der Linden MP, Feitsma AL, le Cessie S, Kern M, Olsson LM, et al. 2009. Association of a singlenucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis. Arthritis Rheum. 60:2242-47
42. Austr. N.Z. Mult. Scler. Genet. Consort. (ANZgene). 2009. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet. 41:824-28
43. Tomer Y. 2001. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid 11:167-69
44. Rudd CE, Taylor A, Schneider H. 2009. CD28 and CTLA-4 coreceptor expression and signal transduction. Immunol. Rev. 229:12-26
45. KoukiT, Sawai Y, GardineCA, FisfalenME, AlegreML, DeGroot LJ. 2000.CTLA-4gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves disease. J. Immunol. 165:6606-11
46. Takara M, Kouki T, DeGroot LJ. 2003. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves disease. Thyroid 13:1083-89
47. Ban Y, Davies TF, Greenberg DA, Kissin A, Marder B, et al. 2003. Analysis of the CTLA-4, CD28 and inducible co-stimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun. 4:586-93
48. Ueda H, Howson JM, Esposito L, Heward J, Snook H, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-11
49. Mayans S, Lackovic K, Nyholm C, Lindgren P, Ruikka K, et al. 2007. CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden. BMCMed. Genet. 8:3
50. Juszczak A, Gupta A, Karavitaki N, Middleton MR, Grossman AB. 2012. Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review. Eur. J. Endocrinol. 167:1-5
51. Burn GL, Svensson L, Sanchez-Blanco C, Saini M, Cope AP. 2011. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett. 585:3689-98
52. Velaga MR, Wilson V, Jennings CE, Owen CJ, Herington S, et al. 2004. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves disease. J. Clin. Endocrinol. Metab. 89:5862-65
53. Begovich AB, Carlton VE, Honigberg LA, Schrodi SJ, Chokkalingam AP, et al. 2004. A missense singlenucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:330-37
54. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, et al. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36:337-38
55. Vang T, Miletic AV, Bottini N, Mustelin T. 2007. Protein tyrosine phosphatase PTPN22 in human autoimmunity. Autoimmunity 40:453-61
56. Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, et al. 2007. Association of the interleukin-2 receptor α(IL-2Rα)/CD25 gene region with Graves disease using a multilocus test and tag SNPs. Clin. Endocrinol. 66:508-12
57. Sakaguchi S, OnoM, Setoguchi R, Yagi H, Hori S, et al. 2006. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212:8-27
58. Abbas AK, Lohr J, Knoechel B. 2007. Balancing autoaggressive and protective T cell responses. J. Autoimmun. 28:59-61
59. Andre S, Tough DF, Lacroix-Desmazes S, Kaveri SV, Bayry J. 2009. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications. Am. J. Pathol. 174:1575-87
60. Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, et al. 2007. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J. Autoimmun. 28:201-7
61. Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, et al. 2011. A genome-wide association study identifies two new risk loci for Graves disease. Nat. Genet. 43:897-901
62. Cooper JD, SimmondsMJ, Walker NM, Burren O, Brand OJ, et al. 2012. Seven newly identified loci for autoimmune thyroid disease. Hum. Mol. Genet. 21:5202-8
63. Jungel A, Ospelt C, Gay S. 2010. What can we learn from epigenetics in the year 2009? Curr. Opin. Rheumatol. 22:284-92